The second draft amendment to the Patent Examination Guidelines (the “
November 3, 2022
4 min read
Alison Wong
As a partner in our Intellectual Property Group in Hong Kong and head of our Life Sciences & Healthcare Sector Group in Asia, I have 20 years' experience in advising clients in the life sciences, healthcare, food & beverage and retail & consumer sectors.
7
Articles
0
Comments
The Second Draft Patent Examination Guidelines on Patent Linkage Invalidation, PTE and PTA
China’s First Supreme Court Patent Linkage Decision
On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on...
September 7, 2022
11 min read
New Draft Implementing Regulations propose key changes for pharmaceuticals in China
On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations...
May 19, 2022
5 min read
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
The US/China Trade Agreement: what could it mean for the Pharma Industry?
Following a long period of negotiation, Phase I of the US-China Trade Agreement was published on 15 January...
February 6, 2020
5 min read
China passed new amendments to the Drug Administration Law
By Alison Wong, Emma Ren, Yang Li
On 26 August 2019, China's National People's Congress passed the final...
September 6, 2019
11 min read
China to accelerate the development of “Smart Supervision System” for drug and medical devices
On 23 May 2019, the National Medical Products Administration ("NMPA") issued...
June 20, 2019
5 min read